Literature DB >> 32878842

Refractory giant cell arteritis: the value of clinical symptoms and imaging.

Alexander Pfeil1, Marcus Franz2, Gunter Wolf1, Martin Freesmeyer3.   

Abstract

Entities:  

Keywords:  cardiovascular medicine; rheumatology

Mesh：

Substances：

Year:  2020        PMID： 32878842      PMCID： PMC7470493          DOI： 10.1136/bcr-2020-237623

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Trial of Tocilizumab in Giant-Cell Arteritis.

Authors:  John H Stone; Katie Tuckwell; Sophie Dimonaco; Micki Klearman; Martin Aringer; Daniel Blockmans; Elisabeth Brouwer; Maria C Cid; Bhaskar Dasgupta; Juergen Rech; Carlo Salvarani; Georg Schett; Hendrik Schulze-Koops; Robert Spiera; Sebastian H Unizony; Neil Collinson
Journal:  N Engl J Med       Date:  2017-07-27       Impact factor: 91.245

Review 2.  The Treatment of Giant Cell Arteritis in Different Clinical Settings.

Authors:  Alexander Pfeil; Peter Oelzner; Peter Hellmann
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

3.  Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.

Authors:  John H Stone; Katie Tuckwell; Sophie Dimonaco; Micki Klearman; Martin Aringer; Daniel Blockmans; Elisabeth Brouwer; Maria C Cid; Bhaskar Dasgupta; Juergen Rech; Carlo Salvarani; Hendrik Schulze-Koops; Georg Schett; Robert Spiera; Sebastian H Unizony; Neil Collinson
Journal:  Arthritis Rheumatol       Date:  2019-07-03       Impact factor: 10.995
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.